COMP <GO>
LH vs UNH // FORWARD P/E MULTIPLE
Labcorp Holdings Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: LH 7
— UNH 8
▲ FORWARD P/E MULTIPLE LEADER: UNH
LAST: $361.39 (-1.84%) • MKT CAP: $29.86B
forward-pe
31.6x
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
forward-pe
17.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.80% | 88.57% | -59.77 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.30% | 11.47% | -3.17 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.6x | 16.4x | +3.15 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.04% | 6.48% | -2.44 | UNH | /fcf-yield <GO> |
| Operating Margin | 9.90% | 4.82% | +5.08 | LH | /operating-margins <GO> |
| Net Profit Margin | 6.30% | 3.14% | +3.16 | LH | /net-margins <GO> |
| Revenue Growth (YoY) | 7.20% | 6.46% | +0.74 | LH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.81% | 2.28% | -1.47 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.58 | 3.12 | +0.46 | LH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | LH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.74% | +0.06 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.5 | 56.0 | +18.49 | LH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.33 | +0.63 | LH | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 31.6x | 17.1x | +14.51 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $29.86B | $364.66B | -$334.80B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LH REV | UNH REV | LH GROSS % | UNH GROSS % | LH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.95B | $447.57B | 28.8% | 88.7% | $1.21B | $16.07B |
| FY 2024 | $13.01B | $400.28B | 27.9% | 88.3% | $1.10B | $20.70B |
| FY 2023 | $12.16B | $371.62B | 44.0% | 89.6% | $780.4M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LH // BETA 0.96
UNH // BETA 0.33